Febuxostat Impurity 33 | CAS 1312815-35-2 - Request Quote
Febuxostat Impurity 33
| SZ CAT No: | SZ-F010066 |
| CAS No | 1312815-35-2 |
| Mol.F. | C12H9NO4S |
| Mol.Wt. | 263.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Febuxostat Impurity 33 is chemically 2-(3-formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylic acid. Febuxostat Impurity 33 is supplied with detailed characterization data compliant with regulatory guideline. Febuxostat Impurity 33 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Febuxostat.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1312815-35-2
Purchase 1312815-35-2
Order 1312815-35-2
Enquire 1312815-35-2
price of 1312815-35-2
1312815-35-2 Supplier
1312815-35-2 Manufacturer
1312815-35-2 Exporter
buy high quality Febuxostat Impurity 33
Purchase Febuxostat Impurity 33
Febuxostat Impurity 33 suppliers
Febuxostat Impurity 33 manufacturers
Febuxostat Impurity 33 price
Order Febuxostat Impurity 33
Enquire Febuxostat Impurity 33
Febuxostat Impurity 33 cost
Febuxostat Impurity 33 Supplier
Febuxostat Impurity 33 Distributor
Febuxostat Impurity 33 for Method Validation
Febuxostat Reference Standard
Febuxostat Impurity 33 for ANDA Filing
Febuxostat Impurity 33 for Forced Degradation Studies
Febuxostat Impurity 33 Identification Standards
Febuxostat Impurity 33 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


